D
David Parkinson
Researcher at University of Plymouth
Publications - 301
Citations - 18694
David Parkinson is an academic researcher from University of Plymouth. The author has contributed to research in topics: Dark energy & Redshift. The author has an hindex of 62, co-authored 283 publications receiving 16221 citations. Previous affiliations of David Parkinson include Washington University in St. Louis & Sheffield Hallam University.
Papers
More filters
Journal ArticleDOI
Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.
Gwendolyn Fyfe,Richard I. Fisher,Steven A. Rosenberg,Mario Sznol,David Parkinson,Arthur C. Louie +5 more
TL;DR: High-dose IL-2 appears to benefit some patients with metastatic renal cell carcinoma by producing durable CRs or PRs, despite severe acute treatment-associated toxicities, and should be considered for initial therapy of patients with appropriately selected metastatic carcinoma.
Journal ArticleDOI
The WiggleZ Dark Energy Survey: mapping the distance-redshift relation with baryon acoustic oscillations
Chris Blake,Eyal A. Kazin,Florian Beutler,Tamara M. Davis,Tamara M. Davis,David Parkinson,Sarah Brough,Matthew Colless,Carlos Contreras,Warrick J. Couch,Scott M. Croom,Darren J. Croton,Michael J. Drinkwater,Karl Forster,David Gilbank,Michael D. Gladders,Karl Glazebrook,Ben Jelliffe,Russell J. Jurek,I-hui Li,Barry F. Madore,D. Christopher Martin,Kevin A. Pimbblet,Gregory B. Poole,Michael Pracy,Michael Pracy,Rob Sharp,Rob Sharp,Emily Wisnioski,David Woods,Ted K. Wyder,Howard K. C. Yee +31 more
TL;DR: In this paper, the authors present measurements of the baryon acoustic peak at redshifts z = 0.44, 0.6 and 0.73 in the galaxy correlation function of the final dataset of the WiggleZ Dark Energy Survey.
Book ChapterDOI
Model selection and multi-model inference
TL;DR: In this paper, the authors focus on the choice of model and the range of values of the parameters which are compatible with the data, which is the statistical problem of model comparison or model selection.
Journal ArticleDOI
Retinoids in cancer therapy.
TL;DR: The antitumor activity demonstrated for retinoids (especially RA) alone and in combination with other agents supports the need for targeted phase II trials to define the spectrum of responsive tumors and for laboratory studies to further delineate the biologic mechanisms associated with therapeutic responses.
Journal ArticleDOI
EphB Signaling Directs Peripheral Nerve Regeneration through Sox2-Dependent Schwann Cell Sorting
Simona Parrinello,Ilaria Napoli,Sara Ribeiro,Patrick Wingfield Digby,Marina Fedorova,David Parkinson,Robin D. S. Doddrell,Masanori Nakayama,Ralf H. Adams,Alison C. Lloyd +9 more
TL;DR: The results identify a link between Ephs and Sox proteins, providing a mechanism by which progenitor cells can translate environmental cues to orchestrate the formation of new tissue.